566 U.S. 399 (2012), 10-844, Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S
Linked as:
Extract
566 U.S. 399 (2012), 10-844, Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 296 F.3d 227 (4th Cir. 2002), 01-2113, AaiPharma Inc. v. Thompson
- Federal Cases - 775 F.Supp.2d 985 (E.D.Mich. 2011), 05-40188, Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories
- Federal Cases - 268 F.3d 1323 (Fed. Cir. 2001), 01-1257, Mylan Pharmaceuticals, Inc. v. Thompson
- Federal Cases - 347 F.3d 1335 (Fed. Cir. 2003), 02-1295, Apotex, Inc. v. Thompson
- Federal Cases - 601 F.3d 1359 (Fed. Cir. 2010), 2010-1001, Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd.